Dexcom INC (DXCM) — 8-K Filings

8-K Filings (14)

• Dexcom Inc. Files 8-K on Director Changes and Compensation — Dec 22, 2025 Risk: low
  On December 19, 2025, Dexcom, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing includes the election
• DexCom Reports Officer Changes and Compensation Details — Oct 27, 2025 Risk: medium
  DexCom, Inc. filed an 8-K on October 27, 2025, reporting events on October 24, 2025. The filing pertains to the departure of directors or certain officers, the
• DexCom CFO Departs; Interim Appointed, New Directors Elected — Sep 16, 2025 Risk: medium
  DexCom, Inc. announced on September 14, 2025, the departure of its Chief Financial Officer, Parth Desai. The company has appointed Jerrod Hill as the interim CF
• DexCom Reports Director/Officer Changes & Compensation — May 13, 2025 Risk: low
  DexCom, Inc. filed an 8-K on May 13, 2025, reporting events as of May 9, 2025. The filing primarily concerns the departure of directors or certain officers, the
• Dexcom Adds New Directors, Updates Executive Pay — May 2, 2025 Risk: low
  On May 1, 2025, Dexcom, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. Specifically, the filing announced the
• DexCom Reports Change in Certifying Accountant — Mar 25, 2025 Risk: low
  DexCom, Inc. filed an 8-K on March 25, 2025, reporting changes in its certifying accountant. The filing indicates that the company's principal accounting firm h
• DexCom CFO Departs; Interim Appointed — Mar 10, 2025 Risk: medium
  DexCom, Inc. announced on March 6, 2025, the departure of its Chief Financial Officer, Jereme Ryan, effective March 10, 2025. The company also announced the app
• Dexcom Inc. Updates Product Pipeline and Strategy — Mar 7, 2025 Risk: low
  On March 4, 2025, Dexcom, Inc. announced a significant development regarding its Continuous Glucose Monitoring (CGM) systems. The company is providing an update
• Dexcom, Inc. Files 8-K with Financial Updates — Feb 13, 2025 Risk: low
  On February 13, 2025, Dexcom, Inc. filed an 8-K report detailing its financial results and operations. The filing includes financial statements and exhibits, pr
• DexCom Files 8-K on Financials — Jan 13, 2025 Risk: low
  DexCom, Inc. filed an 8-K on January 13, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhi
• Dexcom, Inc. Enters Material Definitive Agreement — Dec 23, 2024 Risk: medium
  On December 20, 2024, Dexcom, Inc. entered into a material definitive agreement. The filing does not provide specific details about the agreement, such as the c
• Dexcom, Inc. Files 8-K on Security Holder Vote Matters — May 24, 2024 Risk: low
  On May 22, 2024, Dexcom, Inc. filed an 8-K report detailing the submission of matters to a vote of its security holders. The filing does not disclose specific p
• Dexcom Reports Material Agreements & Equity Sales — Feb 15, 2024 Risk: medium
  DEXCOM, INC. filed an 8-K on February 15, 2024, reporting events that occurred on February 13, 2024. The filing indicates the entry into a material definitive a
• Dexcom Files Routine 8-K, Confirms Nasdaq Listing — Jan 8, 2024
  This 8-K filing from Dexcom, Inc. on January 8, 2024, is a routine administrative update, primarily confirming its status as a publicly traded company on the Na

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX